BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 27385176)

  • 1. Effect of Disease Pathologies on Transporter Expression and Function.
    Atilano-Roque A; Roda G; Fogueri U; Kiser JJ; Joy MS
    J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S205-21. PubMed ID: 27385176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transporter-mediated drug uptake and efflux: important determinants of adverse drug reactions.
    Zolk O; Fromm MF
    Clin Pharmacol Ther; 2011 Jun; 89(6):798-805. PubMed ID: 21471963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Liver Disease on Hepatic Transporter Expression and Function.
    Thakkar N; Slizgi JR; Brouwer KLR
    J Pharm Sci; 2017 Sep; 106(9):2282-2294. PubMed ID: 28465155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging evidence of the impact of kidney disease on drug metabolism and transport.
    Nolin TD; Naud J; Leblond FA; Pichette V
    Clin Pharmacol Ther; 2008 Jun; 83(6):898-903. PubMed ID: 18388866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of Hepatic Transporters in Clinical Disposition of Drugs and Their Metabolites.
    Patel M; Taskar KS; Zamek-Gliszczynski MJ
    J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S23-39. PubMed ID: 27385177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting regulation of ABC efflux transporters in brain diseases: a novel therapeutic approach.
    Potschka H
    Pharmacol Ther; 2010 Jan; 125(1):118-27. PubMed ID: 19896502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of membrane transporters in drug delivery to brain tumors.
    Nies AT
    Cancer Lett; 2007 Aug; 254(1):11-29. PubMed ID: 17275180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional expression of drug transporters in glial cells: potential role on drug delivery to the CNS.
    Ashraf T; Kao A; Bendayan R
    Adv Pharmacol; 2014; 71():45-111. PubMed ID: 25307214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of nuclear receptors in the regulation of drug transporters in the brain.
    Chan GN; Hoque MT; Bendayan R
    Trends Pharmacol Sci; 2013 Jul; 34(7):361-72. PubMed ID: 23769624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood-brain barrier transport of drugs for the treatment of brain diseases.
    Gabathuler R
    CNS Neurol Disord Drug Targets; 2009 Jun; 8(3):195-204. PubMed ID: 19601817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of drug-metabolizing enzymes by local and systemic liver injuries.
    Guo Y; Hu B; Xie Y; Billiar TR; Sperry JL; Huang M; Xie W
    Expert Opin Drug Metab Toxicol; 2016; 12(3):245-51. PubMed ID: 26751558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EUFEPS conference on drug transporters at Copenhagen: integrative approaches in ADME research.
    Meijer DK; Lennernäs H
    Eur J Pharm Sci; 2005 Sep; 26(1):130-43. PubMed ID: 16161216
    [No Abstract]   [Full Text] [Related]  

  • 13. Roles of Hepatic Drug Transporters in Drug Disposition and Liver Toxicity.
    Pan G
    Adv Exp Med Biol; 2019; 1141():293-340. PubMed ID: 31571168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of drug transporter expression in human hepatocytes exposed to the proinflammatory cytokines tumor necrosis factor-alpha or interleukin-6.
    Le Vee M; Lecureur V; Stieger B; Fardel O
    Drug Metab Dispos; 2009 Mar; 37(3):685-93. PubMed ID: 19074973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation-mediated changes in drug transporter expression/activity: implications for therapeutic drug response.
    Cressman AM; Petrovic V; Piquette-Miller M
    Expert Rev Clin Pharmacol; 2012 Jan; 5(1):69-89. PubMed ID: 22142160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug transporters in pharmacokinetics.
    Petzinger E; Geyer J
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Mar; 372(6):465-75. PubMed ID: 16532306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic regulation of drug transporter expression in human tissues.
    Hirota T; Tanaka T; Takesue H; Ieiri I
    Expert Opin Drug Metab Toxicol; 2017 Jan; 13(1):19-30. PubMed ID: 27579666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perspective on the Application of Microphysiological Systems to Drug Transporter Studies.
    Caetano-Pinto P; Stahl SH
    Drug Metab Dispos; 2018 Nov; 46(11):1647-1657. PubMed ID: 30135246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hurdles with using in vitro models to predict human blood-brain barrier drug permeability: a special focus on transporters and metabolizing enzymes.
    Shawahna R; Decleves X; Scherrmann JM
    Curr Drug Metab; 2013 Jan; 14(1):120-36. PubMed ID: 23215812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contributions of Drug Transporters to Blood-Brain Barriers.
    Liu L; Liu X
    Adv Exp Med Biol; 2019; 1141():407-466. PubMed ID: 31571171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.